Pfizer Inc., Forest Laboratories Inc. and Warner-Lambert Co. have been hit with a proposed class action accusing them of coordinating a scheme to mask suicide risks associated with antidepressants Lexapro and Celexa in pediatric patients while simultaneously offering doctors kickbacks to prescribe the drugs for younger patients.
After announcing its $41 billion merger deal with Merck & Co. earlier in the week, Clarinex maker Schering-Plough Corp. on Friday confirmed a $165 million deal that settles a consolidated securities class action over the drugmaker’s alleged failure to disclose information about the manufacturing safety problems that led to a delay of the drug's release.
In a case involving bankrupt copper mining company Asarco LLC, a Texas state court judge has ruled that insurance policy exclusions barring coverage of asbestosis claims do not bar coverage for claims involving other asbestos-related diseases.
A district judge has denied a summary judgment to GlaxoSmithKline PLC, ordering documents the drug manufacturer said contain trade secrets unsealed, and paving the way for punitive damages in a product liability case filed by a user who claims the antidepressant Paxil was a factor in his suicide attempt.
A federal judge has thrown out 44 claims against bankrupt chemical company W.R. Grace & Co. for asbestos-related property damage, affirming a lower court's decision that they were filed too late.
The controversial chemical bisphenol A would be banned from all food and beverage containers in the U.S. under a bill introduced Friday by three members of Congress.
Two North Carolina senators have proposed a bill to establish a federal agency to regulate tobacco, posing an alternative to a similar measure in the U.S. House of Representatives, which would put tobacco under the purview of the U.S. Food and Drug Administration.
The Court of Appeal of the State of California has shot down the state's bid to require canned tuna fish distributors to include warnings to pregnant woman that the products contain methylmercury.
An appeals court affirmed a ruling against Lloyd's of London on Thursday, saying a coverage-in-placement agreement between the insurer and a chemical company limits the claims amount Lloyd's must pay to $10 million per year, and the insurer is required to dole out interest on rollover payments.
In a boost for Hoffmann-La Roche Inc., a New Jersey appellate court has vacated a judgment that awarded $2.6 million to a man who claimed he had to have surgery to remove his colon after taking the acne treatment Accutane.
Cardinal Health Inc. has reported a “potential risk” in one of its drug pumps that could deliver the wrong amount of medicine, just a few weeks after it signed a consent decree with the U.S. Food and Drug Administration clarifying recall protocol for its pumps.
Citing preemption by federal law, a federal judge has dismissed a products liability case against Allergan Inc. accusing the company of making silicone breast implants that were unreasonably dangerous.
Marking the largest U.S. environmental criminal fine in history, a federal judge has reportedly given the green light to a $50 million plea deal by BP PLC to lay to rest charges related to a deadly explosion in 2005 at the oil magnate's Texas City, Texas, plant that killed 15 workers and injured 180 more.
A federal jury rendered a $7.5 million verdict in favor of an American Pop Corn Co. employee one day after the man died of lung and heart failure related to the condition he had claimed was caused by working with buttery flavoring used to make microwave popcorn.
The U.S. Food and Drug Administration has listed Covidien Ltd.'s nationwide recall of some its pediatric tracheostomy tubes as a Class I — the most serious type of recall in which there is “a reasonable probability that use of these products will cause serious injury or death.”
The Obama administration has reportedly tagged former New York City health commissioner Dr. Margaret Hamburg as its first choice for the U.S. Food and Drug Administration’s top job, ending a months-long search.
AstraZeneca LP has prevailed in its battle to keep out evidence of overseas regulatory actions from upcoming trials in multidistrict U.S. litigation over the drugmaker's blockbuster anti-psychotic medication Seroquel.
A man who claims that AstraZeneca Pharmaceuticals LP's Seroquel XR caused his diabetes has asked a New Jersey judge to unseal discovery materials related to clinical trials of the drug in order to share the information with the U.S. Food and Drug Administration as it considers widening the anti-psychotic's use as an antidepressant.
A Delaware senator has introduced a bill that would compel restaurant chains to include calories, sugar and sodium amounts and other nutritional information on their menus.
Federal grand jurors are investigating whether Stryker Corp. subsidiary Stryker Biotech illegally promoted its medical products and filed false reports with the U.S. Food and Drug Administration, the medical technology company revealed Tuesday.